XRP Reserves Surge on Binance, Does It Signal Flash Sell-Offs?
People Are Vibe Coding the Ads Out of Their Smart TVs: Here's How
AMD says EAGLE-4 runs on Instinct MI355X GPUs from day one
Collector_Crypt FLIPS papertrade_xyz IN 24H REVENUE ...
1,606 $BTC (133,125,650 USD) transferred from unknown wallet to unknown wallet...
Quantum-Safe Blockchain Design Could Cut Fees and Network Bloat
Saylor Says Bitcoin Bull Market Is Here, Banks Set to Unlock New Demand
A Post-Vitalik Ethereum Could Still Thrive, Says Co-Founder
Drift hacker washes $63M through Tornado Cash, leaving recovery claims in limbo
opensea MOBILE NOW OPEN TO EVERYONE"MEMES, ART, TRADING CARDS, PERPS. 25+ CHAINS"...
2,361 $BTC (195,689,679 USD) transferred from unknown wallet to unknown wallet...
Trueo Partners with DeFiLlama to Integrate Prediction Markets into DeFi Dashboards
OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work
NEAR Protocol Initiates Vote to Reduce Token Issuance Rate
763 $BTC (63,255,247 USD) transferred from #Coinbase to unknown new wallet...
SpaceX crushes Q3 with $14.6B up 161% as Musk eyes 100,000 Starlinks and...
TRON Reports 1.10 Billion Transactions in Q3 2026, Marking 33.7% Year-Over-Year Growth
CFTC to Host Inaugural AI Forum on Derivatives Market Transformation
Liquid Network Resumes Operations After Hackers Stole 4,000 Bitcoin From Federation WalletRead...
Elon Musk says a Tesla and SpaceX merger would be a good idea | per...
Musk: SpaceX expects ARR of $500 billion to $1 trillion by end of 2027
Utah AG sues Kalshi, pursues profits from prediction market company
YouTube BANS TheBitcoinConf ACCOUNT ...
674 $BTC (55,886,374 USD) transferred from unknown wallet to #Coinbase...
Anthropic recorded an $80B net loss in the first half of 2026...
U.S. CFTC sets agenda for AI forum, exploring trading and agentic finance
JPMorgan Puts a Number on Bitcoin for the First Time: 10% a Year, With a Big Caveat
Blockchain.com Launches Crypto Options Trading With $5…
UK Banks Flooded With Crypto User Complaints, Led by Lloyds and Barclays
Bitcoin Accumulators Are Upping the Ante With Yields Rising
Sui vs Ethereum: Finality, Fees, and Architecture Compared
Data: US Crypto Economy Shrinks as Canada’s Market Expands in 2026
JPMorgan models Bitcoin reaching $385,000 in 10-year bull case despite CEO Jamie Dimon’s criticism
Arkansas Appeals Court Considers Foreign Bitcoin Mining Ownership Restrictions
Wallet Linked to Drift Exploit Sends $61 Million in Ethereum to Tornado Cash
Bitwise, Hyperliquid seek SEC rule changes for token trading, airdrops
DefiLlama AND Trueo_ LAUNCH PREDICTION MARKETS ON PROTOCOL REVENUE AND EXPLOIT ODDS...
Fidelity Reports Surge in Bitcoin Demand Driven by Preferred Stocks
SpaceX Q3 revenue hits $14.575 billion, up 161.39% year-over-year
XRP Price Near $1.32 as Binance Whale Outflows Fall to…
Top Trending Coins (Today) 1. PEARL 2. PENGU 3. PEPE 4. NEAR 5. GRASS 6. CARDS 7. XMR 8. SOL 9....
SoFi Integrates PENGU Token into Banking App, Price Surges 8.9%
BLOOMBERG ODD LOTS’ TheStalwart SAYS HE SHOULDN’T HAVE LAUGHED AS READILY AS HE DID AT THE...
Microsoft, Alphabet, Goldman Sachs Join Growing List of Companies Objecting to Tokenized Stocks
Binance Says Knowing the Platform Helps Users Avoid Scams
Esports Firm Ninjas in Pyjamas Boosts Bitcoin Mining Operation With Added Rigs
Panel at Money20/20 USA Discusses Complexities of Token Use Cases
250,000,000 $USDC (250,092,125 USD) minted at USDC Treasury...
Data: 500 Million USDC Minted on Solana in 5 Minutes
US stock indices mixed: BitMine (BMNR) up 5.68%, Circle (CRCL) up 5.12%
Anthropic IPO Draft: H1 Revenue of $16.3 Billion, Net Loss of $80.7 Billion
Regulatory Update and Recent SEC Actions: October 2026
New Illinois Digital Asset Tax: What Businesses and Taxpayers Need to Know
Tether CEO Rejects Senate Claims Over Iran-Linked USDT
US orders DeepSeek purge from federal systems as Chinese AI rival opens its technology to the world
250,000,000 $USDC (250,092,875 USD) minted at USDC Treasury...
Why Papertrade Won't Let PAPER Trade
ImperialPerps Merges Armada into Main Platform, Closes Phoenix
Citi Downgrades Securitize Amid Revenue Concerns in Tokenization Market
Perpetual Futures Gain Traction in Traditional Finance, Bloomberg Reports
Swiss Regulator Approves First Retail Fund That Holds Bitcoin Directly
Mastercard Begins Rolling Out AI Agent Payments Service With Coinbase, Base
Extended Announces Settlement Transition from Starknet to Arc on October 22
JPMorgan released its 31st annual Long-Term Capital Market Assumptions this week, and
Crypto's Last-Mile Problem Meets Visa's 175 Million Merchants
Nium Crypto as a Service Explained: How the Payments…
Cardano Price Prediction: Top Analyst Sees Sell Signal on ADA
Jeff Yan: Hyperliquid Has No Competitors, Nobody Competes with the InternetHyperliquid Labs...
Elon Musk and Anthropic unveil AI wealth-sharing plans that could reach over $110 billion
OpenAI Acquires Orchestra Bio to Enhance Drug Development Capabilities
OpenAI has acquired Orchestra Bio, a San Francisco-based startup that specializes in developing artificial intelligence agents to assist pharmaceutical companies in managing drug development projects. The financial details of the acquisition have not been disclosed. Orchestra Bio, founded in late 2022, has raised approximately $20 million in seed funding from investors including Andreessen Horowitz, Definition Capital, Insight Partners, and 8VC.
The integration of Orchestra's team and technology into OpenAI's life sciences product line, known as Rosalind, aims to provide biologists and chemists with advanced tools for drug development. OpenAI emphasizes the challenges in the pharmaceutical industry, noting that the process of bringing a new drug to market can take up to 15 years and cost over $2.6 billion, with fewer than 10% of candidate drugs successfully reaching the market after human trials.
Orchestra's AI agents are designed to monitor development tasks, identify issues, analyze the impact of setbacks, and compile critical information to support decision-making for scientists and project leaders. This acquisition follows a similar move by competitor Anthropic, which purchased Coefficient Bio for around $400 million in April 2026, highlighting the growing competition among AI firms in the drug development sector. OpenAI had previously launched GPT-Rosalind, a model tailored for biology and drug discovery, which is currently available to select corporate clients in the United States, including major companies like Amgen and Moderna.
Source: KLEA News